M. Gutniak

Antidiabetogenic Effect of Glucagon-like Peptide-1 (7–36)amide in Normal Subjects and Patients with Diabetes Mellitus

M. Gutniak, Cathrine Ørskov, Jens J. Holst et al. · New England Journal of Medicine · 1992 · 868 citations · Full text

Effects of glucagon-like peptide-1 on endothelial function in type 2 diabetes patients with stable coronary artery disease

Thomas Nyström, M. Gutniak, Qimin Zhang et al. · American Journal of Physiology-Endocrinology and Metabolism · 2004 · 667 citations

Healthy Subjects, Immunology, Endothelial Function +18

Energy intake and appetite are suppressed by glucagon-like peptide-1 (GLP-1) in obese men.

Erik Näslund, Britta Barkeling, N A King et al. · International Journal of Obesity · 1999 · 464 citations

Obesity, Metabolic Syndrome, Energy Homeostasis +12

Glucagon-like peptide 1 increases the period of postprandial satiety and slows gastric emptying in obese men

Erik Näslund, M. Gutniak, Staffan Skogar et al. · American Journal of Clinical Nutrition · 1998 · 303 citations · Full text

Obesity, Metabolic Syndrome, Energy Homeostasis +12

Insulin resistance after abdominal surgery

Anders Thorell, Suad Efendić, M. Gutniak et al. · British journal of surgery · 1994 · 207 citations